Warrants Finder
Your selection:
426 Results
| JU3576 | Vertex Pharmaceuticals Inc./OS/Call [420]/JPM | - | - | 420.000 | call | Vertex Pharmaceuticals Inc. | - | 42.269% | 0.763 | -0.105 | 4.040 | 12/18/2026 | 0.100 | JP Morgan | ||
| SX5K5A | Vertex Pharmaceuticals Inc./OS/Call [420]/SOC | - | - | 420.000 | call | Vertex Pharmaceuticals Inc. | - | 43.004% | 0.733 | -0.102 | 3.875 | 01/15/2027 | 0.100 | Société Générale | ||
| FD1YTM | Vertex Pharmaceuticals Inc./OS/Call [420]/SOC | - | - | 420.000 | call | Vertex Pharmaceuticals Inc. | - | 46.679% | 0.781 | -0.165 | 5.385 | 09/18/2026 | 0.100 | Société Générale | ||
| FE1AXT | Vertex Pharmaceuticals Inc./OS/Call [420]/SOC | - | - | 420.000 | call | Vertex Pharmaceuticals Inc. | - | 44.615% | 0.723 | -0.092 | 3.385 | 03/19/2027 | 0.100 | Société Générale | ||
| FE1AXN | Vertex Pharmaceuticals Inc./OS/Call [420]/SOC | - | - | 420.000 | call | Vertex Pharmaceuticals Inc. | - | 43.245% | 0.737 | -0.110 | 4.111 | 12/18/2026 | 0.100 | Société Générale | ||
| FE58UX | Vertex Pharmaceuticals Inc./OS/Call [420]/SOC | - | - | 420.000 | call | Vertex Pharmaceuticals Inc. | - | 43.242% | 0.724 | -0.079 | 3.070 | 06/17/2027 | 0.100 | Société Générale | ||
| FE58VE | Vertex Pharmaceuticals Inc./OS/Call [420]/SOC | - | - | 420.000 | call | Vertex Pharmaceuticals Inc. | - | 42.587% | 0.729 | -0.061 | 2.576 | 01/21/2028 | 0.100 | Société Générale | ||
| MM215R |  | Vertex Pharmaceuticals Inc./OS/Call [425]/MS | - | - | 425.000 | call | Vertex Pharmaceuticals Inc. | - | 44.324% | 0.722 | -0.011 | 4.106 | 12/18/2026 | 0.010 | Morgan Stanley | |
| MM215S | | Vertex Pharmaceuticals Inc./OS/Call [425]/MS | - | - | 425.000 | call | Vertex Pharmaceuticals Inc. | - | 44.908% | 0.713 | -0.008 | 3.021 | 06/17/2027 | 0.010 | Morgan Stanley | |
| JU31US | Vertex Pharmaceuticals Inc./OS/Call [430]/JPM | - | - | 430.000 | call | Vertex Pharmaceuticals Inc. | - | 42.499% | 0.757 | -0.160 | 6.051 | 09/18/2026 | 0.100 | JP Morgan | ||
| JU3P36 | Vertex Pharmaceuticals Inc./OS/Call [430]/JPM | - | - | 430.000 | call | Vertex Pharmaceuticals Inc. | - | 42.125% | 0.735 | -0.110 | 4.199 | 12/18/2026 | 0.100 | JP Morgan | ||
| JU3WSY | Vertex Pharmaceuticals Inc./OS/Call [430]/JPM | - | - | 430.000 | call | Vertex Pharmaceuticals Inc. | - | 42.404% | 0.709 | -0.104 | 4.035 | 01/15/2027 | 0.100 | JP Morgan | ||
| GW3ZU6 | Vertex Pharmaceuticals Inc./OS/Call [440]/GOLDS | - | - | 440.000 | call | Vertex Pharmaceuticals Inc. | - | 39.733% | 0.709 | -0.101 | 4.245 | 01/15/2027 | 0.100 | Goldman Sachs | ||
| GW4K2D | Vertex Pharmaceuticals Inc./OS/Call [440]/GOLDS | - | - | 440.000 | call | Vertex Pharmaceuticals Inc. | - | 40.009% | 0.684 | -0.089 | 3.853 | 03/19/2027 | 0.100 | Goldman Sachs | ||
| GW5B2A | Vertex Pharmaceuticals Inc./OS/Call [440]/GOLDS | - | - | 440.000 | call | Vertex Pharmaceuticals Inc. | - | 39.581% | 0.687 | -0.077 | 3.422 | 06/17/2027 | 0.100 | Goldman Sachs | ||
| JH5U18 | Vertex Pharmaceuticals Inc./OS/Call [440]/JPM | - | - | 440.000 | call | Vertex Pharmaceuticals Inc. | - | 42.470% | 0.713 | -0.172 | 6.428 | 09/18/2026 | 0.100 | JP Morgan | ||
| JH5SJQ | Vertex Pharmaceuticals Inc./OS/Call [440]/JPM | - | - | 440.000 | call | Vertex Pharmaceuticals Inc. | - | 42.041% | 0.685 | -0.114 | 4.486 | 12/18/2026 | 0.100 | JP Morgan | ||
| JH9BEQ | Vertex Pharmaceuticals Inc./OS/Call [440]/JPM | - | - | 440.000 | call | Vertex Pharmaceuticals Inc. | - | 43.099% | 0.701 | -0.108 | 4.011 | 01/15/2027 | 0.100 | JP Morgan | ||
| JE11YQ | Vertex Pharmaceuticals Inc./OS/Call [440]/JPMD | - | - | 440.000 | call | Vertex Pharmaceuticals Inc. | - | 44.519% | 0.697 | -0.097 | 3.489 | 03/19/2027 | 0.100 | JP Morgan | ||
| JE84H4 | Vertex Pharmaceuticals Inc./OS/Call [440]/JPMD | - | - | 440.000 | call | Vertex Pharmaceuticals Inc. | - | 43.392% | 0.701 | -0.082 | 3.140 | 06/17/2027 | 0.100 | JP Morgan | ||
| SX5K5B | Vertex Pharmaceuticals Inc./OS/Call [440]/SOC | - | - | 440.000 | call | Vertex Pharmaceuticals Inc. | - | 42.276% | 0.683 | -0.107 | 4.171 | 01/15/2027 | 0.100 | Société Générale | ||
| FE4XZ1 | Vertex Pharmaceuticals Inc./OS/Call [440]/SOC | - | - | 440.000 | call | Vertex Pharmaceuticals Inc. | - | 42.301% | 0.684 | -0.115 | 4.469 | 12/18/2026 | 0.100 | Société Générale | ||
| FE58HC | Vertex Pharmaceuticals Inc./OS/Call [440]/SOC | - | - | 440.000 | call | Vertex Pharmaceuticals Inc. | - | 44.580% | 0.707 | -0.180 | 6.205 | 09/18/2026 | 0.100 | Société Générale | ||
| FE58HG | Vertex Pharmaceuticals Inc./OS/Call [440]/SOC | - | - | 440.000 | call | Vertex Pharmaceuticals Inc. | - | 43.178% | 0.699 | -0.094 | 3.564 | 03/19/2027 | 0.100 | Société Générale | ||
| FE58UY | Vertex Pharmaceuticals Inc./OS/Call [440]/SOC | - | - | 440.000 | call | Vertex Pharmaceuticals Inc. | - | 42.326% | 0.687 | -0.080 | 3.253 | 06/17/2027 | 0.100 | Société Générale | ||
| FE58VF | Vertex Pharmaceuticals Inc./OS/Call [440]/SOC | - | - | 440.000 | call | Vertex Pharmaceuticals Inc. | - | 41.869% | 0.697 | -0.062 | 2.698 | 01/21/2028 | 0.100 | Société Générale | ||
| VH625J | | Vertex Pharmaceuticals Inc./OS/Call [440]/VONT | - | - | 440.000 | call | Vertex Pharmaceuticals Inc. | - | 41.274% | 0.682 | -0.105 | 4.258 | 01/15/2027 | 0.100 | Vontobel | |
| GV94RT | Vertex Pharmaceuticals Inc./OS/Call [450]/GOLDS | - | - | 450.000 | call | Vertex Pharmaceuticals Inc. | - | 39.493% | 0.675 | -0.169 | 7.189 | 09/18/2026 | 0.100 | Goldman Sachs | ||
| GV9CUW | Vertex Pharmaceuticals Inc./OS/Call [450]/GOLDS | - | - | 450.000 | call | Vertex Pharmaceuticals Inc. | - | 37.859% | 0.687 | -0.107 | 4.872 | 12/18/2026 | 0.100 | Goldman Sachs | ||
| GV9LTG | Vertex Pharmaceuticals Inc./OS/Call [450]/GOLDS | - | - | 450.000 | call | Vertex Pharmaceuticals Inc. | - | 39.237% | 0.659 | -0.103 | 4.559 | 01/15/2027 | 0.100 | Goldman Sachs | ||
| GU1HKH | Vertex Pharmaceuticals Inc./OS/Call [450]/GOLDS | - | - | 450.000 | call | Vertex Pharmaceuticals Inc. | - | 39.155% | 0.668 | -0.077 | 3.522 | 06/17/2027 | 0.100 | Goldman Sachs | ||
| GW319W | Vertex Pharmaceuticals Inc./OS/Call [450]/GOLDS | - | - | 450.000 | call | Vertex Pharmaceuticals Inc. | - | 39.975% | 0.659 | -0.090 | 3.965 | 03/19/2027 | 0.100 | Goldman Sachs | ||
| GW319Y | Vertex Pharmaceuticals Inc./OS/Call [450]/GOLDS | - | - | 450.000 | call | Vertex Pharmaceuticals Inc. | - | 41.654% | 0.683 | -0.063 | 2.749 | 01/21/2028 | 0.100 | Goldman Sachs | ||
| GN07QL | Vertex Pharmaceuticals Inc./OS/Call [450]/GOLDS | - | - | 450.000 | call | Vertex Pharmaceuticals Inc. | - | 37.456% | 0.668 | -0.136 | 6.386 | 10/16/2026 | 0.100 | Goldman Sachs | ||
| JH5U1M | Vertex Pharmaceuticals Inc./OS/Call [450]/JPM | - | - | 450.000 | call | Vertex Pharmaceuticals Inc. | - | 41.902% | 0.667 | -0.179 | 6.886 | 09/18/2026 | 0.100 | JP Morgan | ||
| JH5SJR | Vertex Pharmaceuticals Inc./OS/Call [450]/JPM | - | - | 450.000 | call | Vertex Pharmaceuticals Inc. | - | 41.245% | 0.654 | -0.115 | 4.721 | 12/18/2026 | 0.100 | JP Morgan | ||
| JH9BER | Vertex Pharmaceuticals Inc./OS/Call [450]/JPM | - | - | 450.000 | call | Vertex Pharmaceuticals Inc. | - | 42.399% | 0.652 | -0.109 | 4.309 | 01/15/2027 | 0.100 | JP Morgan | ||
| MJ860U | | Vertex Pharmaceuticals Inc./OS/Call [450]/MS | - | - | 450.000 | call | Vertex Pharmaceuticals Inc. | - | 41.751% | 0.654 | -0.012 | 4.677 | 12/18/2026 | 0.010 | Morgan Stanley | |
| MK9KUZ | | Vertex Pharmaceuticals Inc./OS/Call [450]/MS | - | - | 450.000 | call | Vertex Pharmaceuticals Inc. | - | 43.248% | 0.665 | -0.008 | 3.278 | 06/17/2027 | 0.010 | Morgan Stanley | |
| MM5JNY | | Vertex Pharmaceuticals Inc./OS/Call [450]/MS | - | - | 450.000 | call | Vertex Pharmaceuticals Inc. | - | 46.368% | 0.659 | -0.020 | 6.360 | 09/18/2026 | 0.010 | Morgan Stanley | |
| MN04AE | | Vertex Pharmaceuticals Inc./OS/Call [450]/MS | - | - | 450.000 | call | Vertex Pharmaceuticals Inc. | - | 46.304% | 0.681 | -0.007 | 2.617 | 12/17/2027 | 0.010 | Morgan Stanley | |
| MN6FTA | | Vertex Pharmaceuticals Inc./OS/Call [450]/MS | - | - | 450.000 | call | Vertex Pharmaceuticals Inc. | - | 44.032% | 0.657 | -0.010 | 3.683 | 03/19/2027 | 0.010 | Morgan Stanley | |
| SX5KSM | Vertex Pharmaceuticals Inc./OS/Call [450]/SOC | - | - | 450.000 | call | Vertex Pharmaceuticals Inc. | - | 43.613% | 0.660 | -0.186 | 6.703 | 09/18/2026 | 0.100 | Société Générale | ||
| FA53J9 | Vertex Pharmaceuticals Inc./OS/Call [450]/SOC | - | - | 450.000 | call | Vertex Pharmaceuticals Inc. | - | 41.669% | 0.652 | -0.116 | 4.692 | 12/18/2026 | 0.100 | Société Générale | ||
| FD1ZF7 | Vertex Pharmaceuticals Inc./OS/Call [450]/SOC | - | - | 450.000 | call | Vertex Pharmaceuticals Inc. | - | 43.074% | 0.656 | -0.096 | 3.752 | 03/19/2027 | 0.100 | Société Générale | ||
| FE58U5 | Vertex Pharmaceuticals Inc./OS/Call [450]/SOC | - | - | 450.000 | call | Vertex Pharmaceuticals Inc. | - | 42.116% | 0.670 | -0.071 | 3.035 | 09/17/2027 | 0.100 | Société Générale | ||
| FE58U9 | Vertex Pharmaceuticals Inc./OS/Call [450]/SOC | - | - | 450.000 | call | Vertex Pharmaceuticals Inc. | - | 41.953% | 0.678 | -0.065 | 2.813 | 12/17/2027 | 0.100 | Société Générale | ||
| VJ5DDE | | Vertex Pharmaceuticals Inc./OS/Call [450]/VONT | - | - | 450.000 | call | Vertex Pharmaceuticals Inc. | - | 39.023% | 0.684 | -0.110 | 4.765 | 12/18/2026 | 0.100 | Vontobel | |
| VY41Y4 | | Vertex Pharmaceuticals Inc./OS/Call [450]/VONT | - | - | 450.000 | call | Vertex Pharmaceuticals Inc. | - | 44.552% | 0.666 | -0.085 | 3.201 | 06/17/2027 | 0.100 | Vontobel | |
| VY5LM5 | | Vertex Pharmaceuticals Inc./OS/Call [450]/VONT | - | - | 450.000 | call | Vertex Pharmaceuticals Inc. | - | 41.646% | 0.664 | -0.178 | 6.955 | 09/18/2026 | 0.100 | Vontobel |